Established and lead the Life Sciences Group (LSG) global Market Development Team. Commercially oriented group dedicated to increasing awareness, influencing, and fostering portfolio growth by promoting increased usage, varied usage, new users, or new use cases. Leadership & Strategy: Formed a comprehensive team dedicated to market development across the entire life science portfolio. Manage a diverse group of professionals (senior-level), including overseeing people managers. Develops and implements tailored strategies for each business unit or profit center to drive growth and market expansion.Span of Control: Holds profit and loss responsibility. Supports a $1 billion portfolio spanning seven profit/business centers. Direct reports with people managers. Oversee multiple functions with distinct contributions.Scientific & Medical Affairs: Oversees the management of scientific & medical affairs, ensuring engagement with key opinion leaders (KOLs) and fostering scientific collaborations, partner alliances, and professional societies and consortia. Team management of hundreds of strategic collaborations globally, facilitating partnerships and alliances; evidence generation to support the product life cycle. Establish and manage scientific advisory boards to guide strategic initiatives and new product development.Marketing Applications: Team manages over 300 marketing application activities annually to support product life cycle and market growth. Product concept derisking through new product Introduction, evidence generation, campaigns, and collaborations.Market Intelligence: Conducts thorough market intelligence activities, including competitive analysis, market trends evaluation, and reporting to inform strategic decisions and support business growth. Support M&A activities, including due diligence processes.Commercial Development: Built and lead team consisting of sales and field application scientists to drive adoption of technology globally.

Celsee was a start-up company that specialized in circulating tumor cell (CTC) isolation and single-cell isolation technologies. Built and lead high-performing teams, sales and marketing, responsible for managing global marketing efforts and driving the global commercial and corporate strategy.

Leadership: Part of the executive team, driving corporate and commercial strategy with a go-to-market plan for single-cell genomics and proteomics products. Co-responsible for strategic and institutional fund-raising investments and due diligence processes. Built and led a global marketing department responsible for commercial strategy, brand strategy, product marketing, digital marketing, and demand generation.Strategic Marketing: Developed and presented strategies and models, leading analysis, recommendations, and communication for key decision-making processes. Brand: Implemented a rebranding strategy, including logo redesign and complete website makeover, increasing web traffic and prospect velocity to opportunities.Commercial Strategy: Identified and implemented strategies to influence key stakeholders across research, translational, and pharma industries, emphasizing genomics and proteomics. Established strategic alliances with key opinion leaders (KOLs) and led early access programs coordinated across sales, service, and field application support.

Implemented commercialization and market expansion strategies for single-cell genomics and cancer biology.

Fluidigm creates and manufactures innovative technologies and life-science tools designed to revolutionize biology through a relentless pursuit of scientific truth. Its core technologies are based on microfluidics and mass cytometry, and enable the exploration and analysis of individual cells, as well as the industrial application of genomics.Responsible for 3 key product lines, which include Single-Cell Genomics, High-Throughput Genomics, and Mass Cytometry (including the merging Imaging Mass Cytometry). Direct sales of capital equipment, consumables, and point-of-sale service. Manage entire sales process from lead generation and qualification through close. Build consensus within customer organization; working with KOLs and identifying key mobilizers to drive internal stake. Manage team of consumable account managers, product specialists, and field applications scientists to drive closure of business and increase consumable pull-through.

ProteinSimple helps researchers gain a better understanding of proteins and their role in disease. They develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins. Their goal is to make protein analysis simpler, more quantitative and affordable. Their comprehensive portfolio of tools includes immunoassay systems that quantify protein expression and systems that probe the structure and purity of protein-based therapeutics.Responsible for identifying emerging markets to provide technical presentations to increase product awareness of the Simple Western product line, including instrumentation, consumables, and service contracts. Provided account management to bio-pharma, drug discovery labs, agricultural, biotech, CRO, government, and academic markets. Identified new opportunities and cultivated existing relationships to ensure consistent market share growth, revenue, and profitability. Equipment sales of $50,000—$315,000 per opportunity.

BioTek is a world leader in the design and manufacture of high performance, microplate based, life science instrumentation and software used to accelerate drug discovery and aid in the advancement of life science research.Responsible for selling capital equipment: microplate instrumentation covering multi-detection plate readers, multi-detection fluorescence microscopes, plate washers, liquid handling, and automation. Provided technical demonstrations to HTS drug discovery labs, agricultural, biotech, CRO, government, and academic markets. Identified new opportunities and cultivated existing relationships to provide consistent market share growth, revenue, and profitability. Provided support and direct sales growth in the territories of Indiana, Kentucky, and Southwest Ohio, while also leveraging the support through 17 distributor representatives.

Designed and conducted biomedical experiments to characterize the mechanisms through which mammalian proteases are activated. Established new methodologies drawing on the expertise of institutional and area collaborators. Trained and mentored students and research staff on the operation of scientific instrumentation and the design of experimental protocols. Served as liaison representing the needs of research fellows to an oversight committee. Reviewed manuscripts and grant proposals for lab faculty and staff.• Awarded the NIH T32 Cleveland Clinic Orthopaedic Research Center Postdoctoral Fellowship (Salary and Supplies for 2 Years)• Increased visibility and provided new project leads – Established Proteomics as new lab methodology• Profiled protein levels between normal and pathological conditions using Proteomics• Pitched innovative research methods – Acquired new lab materials• Presented scientific findings at the American Society for Matrix Biology National meeting in San Diego

Devised protocols to probe scientific hypotheses. Trained graduate and undergraduates on the design and execution of investigational science. Negotiated the acquisition of new technology to improve research productivity and quality. Characterized the biosynthesis and catalytic activity of proteins isolated from infectious bacteria using protein chemistry. Taught undergraduate laboratories and recitation classes. Biochemically characterized proteins and developed novel purification strategies.• Awarded Research and Teaching Assistantships capped with an additional Merit Scholarship (Salary and Tuition, 2001-2007)• Awarded ASBMB and ACS Graduate Student travel awards to attend the Experimental Biology National Meeting, Washington D.C. (2007)• Successfully proposed the acquisition of an FPLC, UV-Vis Microplate Reader, PCR and gel chromatography equipment• Streamlined processes to reduce data acquisition time by 600%, resulting in 80% lower operating cost• Elucidated key amino acids involved in catalysis for bacterial enzymes and determined their 3-dimensional structure• Authored and co-authored peer-reviewed manuscripts

Developed protocols to understand the polymerization of microtubules. Attended departmental and institutional meetings, presenting data to staff scientist. Collaborated with scientists from other institutes on experimental development. • Developed new techniques to catalog variances among microtubules – creating the first record of microtubule orthologs• Demonstrated effectiveness of new protocols

During the summers I surveyed and treated mosquito breeding areas to decrease the risk of mosquito-borne disease and nuisance mosquito species to the citizens and visitors of summit county.